rethinkTHC Search
Menu
Study breakdown

Pre-Employment THC Positive Tests Jumped 683% After California Legalization

ObservationalModerate evidence
The takeaway

Pre-employment urine drug screening positivity for THC increased from 0.12% to 0.94% between 2017 and 2022 at a California hospital clinic, with the proportion of positive females rising from 25% to 62%.

Occupational medicine physicians, HR professionals, employment law practitioners, and cannabis policy researchers.

What the researchers found

THC-COOH positivity rate increased from 0.12% in 2017 to 0.94% in 2022 (Cochran-Armitage Z=5.19, p<0.001), a 683% relative increase. Among positive cases, 76% were aged 20-39 (mean: 29 years). The female proportion of positive cases rose dramatically from 25% to 62.2%. Median THC-COOH levels ranged from 60 to 176.5 ng/mL.

Why it matters

Pre-employment drug testing policies were designed when cannabis was illegal everywhere. As legalization spreads, the sharp increase in positive tests raises questions about whether cannabis testing should remain part of employment screening, especially since urine tests detect past use rather than impairment.

The numbers in context

21,546 screenings total. 92 THC-positive (0.44% overall). 2017: 0.12% (4/3,215). 2022: 0.94% (45/4,784). 683% relative increase. Female proportion of positives: 25% to 62.2%. Mean age of positives: 29 years. Median THC-COOH: 145.0 ng/mL (IQR: 309.5).

How the study worked

Retrospective analysis of 21,546 de-identified pre-employment urine drug screenings from 2017-2022 at a university-based hospital occupational medicine clinic. Initial immunoassay screening (50 ng/mL cutoff) followed by GC-MS confirmation (15 ng/mL). Cochran-Armitage trend test assessed temporal trends.

What this study cannot tell us

Single clinic at one hospital system. Cannot determine if positive results reflected increased cannabis use or decreased abstinence before testing. Missing demographic data for the total screening population limits subgroup analysis. Low overall positivity rate means small absolute numbers of positive cases.

How to read the evidence

Large screening sample with confirmed results and validated trend analysis, but single-site design and missing demographic data for the overall population limit conclusions.

When this study was published

Published 2025, analyzing 2017-2022 screening data.

The bigger picture

California's Assembly Bill 2188 (2024) restricts employers from using cannabis urine testing in hiring decisions, recognizing that these tests detect past use rather than current impairment. This study provides the empirical backdrop for that legislative shift, showing that positive rates increased substantially after legalization while the overall rate remained under 1%.

Questions still open

  • Whether the continued increase in female positivity reflects changing cannabis use patterns or changing workforce demographics
  • How employers will adapt testing policies as impairment-focused testing replaces urine screening

Common questions

Does a positive THC test mean someone was impaired at work?
No. Urine THC metabolite testing detects past cannabis use, not current impairment. THC-COOH can remain detectable for days to weeks after last use. This disconnect between detection and impairment is driving the shift toward impairment-focused testing policies.
Why did the female positive rate increase so much?
The dramatic shift from 25% to 62% female among positive cases mirrors broader trends showing women's cannabis use increasing faster than men's post-legalization, consistent with other studies showing the cannabis gender gap is narrowing.

Read the original research

Pre-employment urine drug screening: examining trends in THC-COOH positivity rates post-legalization of recreational cannabis in California - a retrospective review.

Journal of occupational medicine and toxicology (London, England), 20(1), 29

Citation

Sharip, Akbar; Razavi, Roshan. (2025). Pre-employment urine drug screening: examining trends in THC-COOH positivity rates post-legalization of recreational cannabis in California - a retrospective review.. Journal of occupational medicine and toxicology (London, England), 20(1), 29. https://doi.org/10.1186/s12995-025-00468-3

Explore the wider topic